Cooper Hannah H

Show results for

Unknown (28)
Metabolomics (2)

Repository

MetaboLights (2)

Technology Type

Mass spectrometry (1)
Mass spectrometry assay (1)

Instrument Platform

6520 Q-TOF LC/MS (Agilent) (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2024 (1)
2016 (1)

CHEBI ID

CHEBI:116314 (1)
CHEBI:132244 (1)
CHEBI:14314 (1)
CHEBI:15428 (1)
CHEBI:15859 (1)
CHEBI:16313 (1)
CHEBI:16449 (1)
CHEBI:16704 (1)
CHEBI:16737 (1)
CHEBI:16742 (1)
CHEBI:16750 (1)
CHEBI:16811 (1)
CHEBI:16958 (1)
CHEBI:17126 (1)
CHEBI:17295 (1)
CHEBI:17368 (1)
CHEBI:17562 (1)
CHEBI:17568 (1)
CHEBI:17596 (1)
CHEBI:17634 (1)
CHEBI:17821 (1)
CHEBI:17822 (1)
CHEBI:17858 (1)
CHEBI:17895 (1)
CHEBI:18237 (1)
CHEBI:18349 (1)
CHEBI:22653 (1)
CHEBI:22660 (1)
CHEBI:24898 (1)
CHEBI:26986 (1)

Metabolite Name

Thymine (2)
(+)-.alpha.-tocopherol (1)
(+)-catechin (1)
(+)-isocorydine (1)
(-)-.alpha.-kainic acid (1)
(-)-epigallocatechin (1)
(-)-myrtenol (1)
(2e,4e)-hexa-2,4-dienoic acid (1)
(2e,4e,12z)-n-(2-methylpropyl)octadeca-2,4,12-trienamide (1)
(3.beta.,5.alpha.)-4,4-dimethylcholesta-8,14,24-trien-3-ol (1)
(4r)-4-((1r,3s,5s,7r,9s,10s,12s,13r,14s,17r)-1,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(r)-butyrylcarnitine (1)
(s)-cotinine n-oxide (1)
.alpha.-L-Glu-L-Tyr (1)
.alpha.-ionone (1)
.beta.-muricholic acid (1)
.beta.-nicotinamide adenine dinucleotide, reduced(NADH) (1)
.beta.-sitosterol (1)
.beta.-thujaplicin (1)
.delta.-dodecalactone (1)
.gamma.-aminobutyric acid (1)
.gamma.-l-glu-.epsilon.-l-lys (1)
.omega.-3 arachidonic acid (1)
1,2-di-(9z,12z,15z-octadecatrienoyl)-sn-glycero-3-phosphocholine (1)
1,2-dilinolenoyl-sn-glycero-3-phosphoethanolamine (1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n,n-dimethyl (1)
1,2-dioleoyl-sn-glycerol (1)
1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (1)
1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine (1)

Release Date

2021 (9)
2023 (3)
2022 (3)
2018 (3)
2025 (2)
2024 (2)
2014 (2)
2026 (1)
2015 (1)
2010 (1)
2008 (1)

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Excoriation Disorder Is Characterized by Systemic Glutamatergic Dysfunction

Excoriation disorder (ED), also known as neurotic excoriations, is a psychocutaneous disorder characterized by repetitive, compulsive picking of the skin leading to secondary tissue damage. ED carries an estimated prevalence of 1.4%, and is associated with significant social dysfunction, as patie...

2024-04-03 | MTBLS9118 | MetaboLights

Lecanemab over a two-year duration: Key insights from a regional specialty medical center.

Not available

S-EPMC12860706 | biostudies-literature

Metabolomic profiling of Fraxinus excelsior genotypes tolerant or susceptible to ash dieback disease reveals changes in iridoid glycosides

European common ash, Fraxinus excelsior L., is currently threatened by Ash dieback (ADB) caused by the fungus, Hymenoscyphus fraxineus. To detect and identify metabolites that may be products of pathways important in contributing to resistance against H. fraxineus we performed untargeted metabolomic...

2016-11-09 | MTBLS372 | MetaboLights

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.

Not available

S-EPMC2745911 | biostudies-literature

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8084355 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

Not available

S-EPMC9333998 | biostudies-literature

International norms for adult handgrip strength: A systematic review of data on 2.4 million adults aged 20 to 100+ years from 69 countries and regions.

Not available